{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:47:12Z","timestamp":1792068432395,"version":"4.4.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013699","name":"Bundesministerium f\u00fcr Bildung, Wissenschaft und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009397","name":"Medizinischen Fakult\u00e4t, Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Among genetic paroxysmal movement disorders, variants in ion channel coding genes constitute a major subgroup. Loss-of-function (LOF) variants in <jats:italic>KCNA1<\/jats:italic>, the gene coding for K<jats:sub>V<\/jats:sub>1.1 channels, are associated with episodic ataxia type 1 (EA1), characterized by seconds to minutes-lasting attacks including gait incoordination, limb ataxia, truncal instability, dysarthria, nystagmus, tremor, and occasionally seizures, but also persistent neuromuscular symptoms like myokymia or neuromyotonia. Standard treatment has not yet been developed, and different treatment efforts need to be systematically evaluated.<\/jats:p><jats:p><jats:bold>Objective and Methods:<\/jats:bold> Personalized therapeutic regimens tailored to disease-causing pathophysiological mechanisms may offer the specificity required to overcome limitations in therapy. Toward this aim, we (i) reviewed all available clinical reports on treatment response and functional consequences of <jats:italic>KCNA1<\/jats:italic> variants causing EA1, (ii) examined the potential effects on neuronal excitability of all variants using a single compartment conductance-based model and set out to assess the potential of two sodium channel blockers (SCBs: carbamazepine and riluzole) to restore the identified underlying pathophysiological effects of K<jats:sub>V<\/jats:sub>1.1 channels, and (iii) provide a comprehensive review of the literature considering all types of episodic ataxia.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Reviewing the treatment efforts of EA1 patients revealed moderate response to acetazolamide and exhibited the strength of SCBs, especially carbamazepine, in the treatment of EA1 patients. Biophysical dysfunction of K<jats:sub>V<\/jats:sub>1.1 channels is typically based on depolarizing shifts of steady-state activation, leading to an LOF of <jats:italic>KCNA1<\/jats:italic> variant channels. Our model predicts a lowered rheobase and an increase of the firing rate on a neuronal level. The estimated concentration dependent effects of carbamazepine and riluzole could partially restore the altered gating properties of dysfunctional variant channels.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> These data strengthen the potential of SCBs to contribute to functional compensation of dysfunctional K<jats:sub>V<\/jats:sub>1.1 channels. We propose riluzole as a new drug repurposing candidate and highlight the role of personalized approaches to develop standard care for EA1 patients. These results could have implications for clinical practice in future and highlight the need for the development of individualized and targeted therapies for episodic ataxia and genetic paroxysmal disorders in general.<\/jats:p>","DOI":"10.3389\/fneur.2021.703970","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T11:49:09Z","timestamp":1631188149000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in KCNA1-Associated Episodic Ataxia and a Comprehensive Review of the Literature"],"prefix":"10.3389","volume":"12","author":[{"given":"Stephan","family":"Lauxmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Sonnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils A.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bosselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas V.","family":"Wuttke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike B. S.","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Lerche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Benda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josua","family":"Kegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ng1094-136","article-title":"Episodic ataxia\/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1","volume":"8","author":"Browne","year":"1994","journal-title":"Nat Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/j.1460-9568.1995.tb00641.x","article-title":"Immunohistochemical localization of five members of the KV1 channel subunits: contrasting subcellular locations and neuron-specific co-localizations in rat brain","volume":"7","author":"Veh","year":"1995","journal-title":"Eur J Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nn1025","article-title":"A mouse model of episodic ataxia type-1","volume":"6","author":"Herson","year":"2003","journal-title":"Nat Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/brain\/122.5.817","article-title":"A novel mutation in the human voltage-gated potassium channel gene (KV1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy","volume":"122","author":"Zuberi","year":"1999","journal-title":"Brain."},{"key":"B5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nurt.2007.01.010","article-title":"Episodic ataxia type 1: a neuronal potassium channelopathy","volume":"4","author":"Rajakulendran","year":"2007","journal-title":"Neurotherapeutics."},{"key":"B6","doi-asserted-by":"publisher","first-page":"648031","DOI":"10.3389\/fneur.2021.648031","article-title":"Paroxysmal genetic movement disorders and epilepsy","volume":"12","author":"de Gusmao","year":"2021","journal-title":"Front Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/brain\/awu012","article-title":"Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation","volume":"137","author":"Graves","year":"2014","journal-title":"Brain."},{"key":"B8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0022-510X(75)90191-4","article-title":"Hereditary myokymia and periodic ataxia","volume":"25","author":"VanDyke","year":"1975","journal-title":"J Neurol Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/brain\/113.5.1361","article-title":"Familial paroxysmal kinesigenic ataxia and continuous myokymia","volume":"113","author":"Brunt","year":"1990","journal-title":"Brain."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/brain\/awm126","article-title":"Primary episodic ataxias: diagnosis, pathogenesis and treatment","volume":"130","author":"Jen","year":"2007","journal-title":"Brain."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1517\/14656566.2012.706278","article-title":"Retigabine\/ezogabine, a KCNQ\/K(V)7 channel opener: pharmacological and clinical data","volume":"13","author":"Orhan","year":"2012","journal-title":"Expert Opin Pharmacother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"12102","DOI":"10.1038\/ncomms12102","article-title":"Action potential broadening in a presynaptic channelopathy","volume":"7","author":"Begum","year":"2016","journal-title":"Nat Commun."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.24.441205","article-title":"In vitro effects of S-Licarbazepine as a potential precision therapy on SCN8A variants causing neuropsychiatric disorders","author":"Bayraktar","year":"2021","journal-title":"bioRxiv"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1046\/j.1460-9568.2000.00242.x","article-title":"Riluzole inhibits the persistent sodium current in mammalian CNS neurons","volume":"12","author":"Urbani","year":"2000","journal-title":"Eur J Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/epi4.12379","article-title":"Persistent sodium current blockers can suppress seizures caused by loss of low-threshold D-type potassium currents: predictions from an in silico study of KV1 channel disorders","volume":"5","author":"Du","year":"2020","journal-title":"Epilepsia Open."},{"key":"B16","first-page":"227","article-title":"Neuroprotective agent riluzole dramatically slows inactivation of KV1.4 potassium channels by a voltage-dependent oxidative mechanism","volume":"299","author":"Xu","year":"2001","journal-title":"J Pharmacol Exp Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00422-008-0263-8","article-title":"Minimal Hodgkin-Huxley type models for different classes of cortical and thalamic neurons","volume":"99","author":"Pospischil","year":"2008","journal-title":"Biol Cybern."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1523\/JNEUROSCI.14-08-04588.1994","article-title":"Localization of KV1.1 and KV1.2. two K channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain","volume":"14","author":"Wang","year":"1994","journal-title":"J Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0896-6273(92)90127-Y","article-title":"Differential expression of K+ channel mRNAs in the rat brain and down-regulation in the hippocampus following seizures","volume":"8","author":"Tsaur","year":"1992","journal-title":"Neuron."},{"key":"B20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1749-6632.1991.tb25931.x","article-title":"Multiple modes of neuronal population activity emerge after modifying specific synapses in a model of the CA3 region of the hippocampus","volume":"627","author":"Traub","year":"1991","journal-title":"Ann N Y Acad Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4992\/jjpsy.60.245","article-title":"A study of the process of self-concept formation in adolescence: an investigation of self-descriptions using the Twenty Statement Test (TST)","volume":"60","author":"Yamada","year":"1989","journal-title":"Shinrigaku Kenkyu."},{"key":"B22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fncel.2019.00358","article-title":"A kinetic map of the homomeric voltage-gated potassium channel (Kv) family","volume":"13","author":"Ranjan","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1113\/jphysiol.2006.107094","article-title":"Essential role of the persistent sodium current in spike initiation during slowly rising inputs in mouse spinal neurones","volume":"574","author":"Kuo","year":"2006","journal-title":"J Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/bph.12534","article-title":"Properties of human brain sodium channel \u03b1-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine","volume":"171","author":"Qiao","year":"2014","journal-title":"Br J Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/brain\/awu339","article-title":"Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug","volume":"138","author":"Doeser","year":"2015","journal-title":"Brain."},{"key":"B26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0306-4522(97)00604-0","article-title":"Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons","volume":"85","author":"Zona","year":"1998","journal-title":"Neuroscience."},{"key":"B27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1212\/01.wnl.0000176069.64200.28","article-title":"Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A","volume":"65","author":"Imbrici","year":"2005","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"212576","DOI":"10.7573\/dic.212576","article-title":"Therapy of episodic ataxias: case report and review of the literature","volume":"8","author":"Orsucci","year":"2019","journal-title":"Drugs Context."},{"key":"B29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1212\/WNL.0b013e318225ab07","article-title":"A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias","volume":"77","author":"Strupp","year":"2011","journal-title":"Neurology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1212\/01.WNL.0000101675.61074.50","article-title":"Clinical spectrum of episodic ataxia type 2","volume":"62","author":"Jen","year":"2004","journal-title":"Neurology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1113\/jphysiol.2009.186437","article-title":"Genetic and functional characterisation of the P\/Q calcium channel in episodic ataxia with epilepsy","volume":"588","author":"Rajakulendran","year":"2010","journal-title":"J Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jns.2010.01.010","article-title":"Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2","volume":"291","author":"Mantuano","year":"2010","journal-title":"J Neurol Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/epi.16316","article-title":"Both gain-of-function and loss-of-function de novo CACNA 1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome","volume":"60","author":"Jiang","year":"2019","journal-title":"Epilepsia."},{"key":"B34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/ng0197-62","article-title":"Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel","volume":"15","author":"Zhuchenko","year":"1997","journal-title":"Nat Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1086\/302909","article-title":"Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia","volume":"66","author":"Escayg","year":"2000","journal-title":"Am J Hum Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1212\/CPJ.0000000000000697","article-title":"Clinical manifestations of episodic ataxia type 5","volume":"9","author":"Gonzalez Sanchez","year":"2019","journal-title":"Neurol Clin Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1008625","DOI":"10.1371\/journal.pgen.1008625","article-title":"A homozygous missense variant in CACNB4 encoding the auxiliary calcium channel beta4 subunit causes a severe neurodevelopmental disorder and impairs channel and nonchannel functions","volume":"16","author":"Coste de Bagneaux","year":"2020","journal-title":"PLoS Genet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1196\/annals.1444.016","article-title":"Hereditary episodic ataxias","volume":"1142","author":"Jen","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/01.wnl.0000172638.58172.5a","article-title":"Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures","volume":"65","author":"Jen","year":"2005","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s10038-017-0365-z","article-title":"A novel mutation in SLC1A3 causes episodic ataxia","volume":"63","author":"Iwama","year":"2018","journal-title":"J Hum Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archneurol.2008.535","article-title":"Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake","volume":"66","author":"de Vries","year":"2009","journal-title":"Arch Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"13855","DOI":"10.1038\/s41598-017-14254-7","article-title":"Genetic variants associated with episodic ataxia in Korea","volume":"7","author":"Choi","year":"2017","journal-title":"Sci Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1093\/brain\/awv088","article-title":"Reply: evaluation of exome sequencing variation in undiagnosed ataxias","volume":"138","author":"Pyle","year":"2015","journal-title":"Brain J Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"13913","DOI":"10.1038\/s41598-017-14176-4","article-title":"Impaired K+ binding to glial glutamate transporter EAAT1 in migraine","volume":"7","author":"Kovermann","year":"2017","journal-title":"Sci Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog Neurobiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"fcaa022","DOI":"10.1093\/braincomms\/fcaa022","article-title":"Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6","volume":"2","author":"Kovermann","year":"2020","journal-title":"Brain Commun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/glia.23098","article-title":"Glutamate transporter-associated anion channels adjust intracellular chloride concentrations during glial maturation","volume":"65","author":"Untiet","year":"2017","journal-title":"Glia."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1093\/brain\/aws255","article-title":"A point mutation associated with episodic ataxia 6 increases glutamate transporter anion currents","volume":"135","author":"Winter","year":"2012","journal-title":"Brain J Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ejhg.2013.173","article-title":"A novel locus for episodic ataxia: UBR4 the likely candidate","volume":"22","author":"Conroy","year":"2014","journal-title":"Eur J Hum Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0378-3782(98)00090-5","article-title":"Calcium signaling molecules in human cerebellum at midgestation and in ataxia","volume":"54","author":"Zecevic","year":"1999","journal-title":"Early Hum Dev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1212\/WNL.0b013e3181f8812e","article-title":"SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain","volume":"75","author":"Liao","year":"2010","journal-title":"Neurology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pediatrneurol.2016.11.008","article-title":"SCN2A p.Ala263Val variant a phenotype of neonatal seizures followed by paroxysmal ataxia in toddlers","volume":"67","author":"Gorman","year":"2017","journal-title":"Pediatr Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ejpn.2019.03.001","article-title":"Clinical and genetic spectrum of SCN2A-associated episodic ataxia","volume":"23","author":"Schwarz","year":"2019","journal-title":"Eur J Paediatr Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00415-015-7984-0","article-title":"Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia","volume":"263","author":"Schwarz","year":"2016","journal-title":"J Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pediatrneurol.2016.02.010","article-title":"The genetic homogeneity of CAPOS syndrome: four new patients with the c.2452G>A (p.Glu818Lys) mutation in the ATP1A3 gene","volume":"59","author":"Maas","year":"2016","journal-title":"Pediatr Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1212\/WNL.0b013e3182752c5a","article-title":"PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine","volume":"79","author":"Gardiner","year":"2012","journal-title":"Neurology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pediatrneurol.2013.09.002","article-title":"A three-year-old boy with glucose transporter type 1 deficiency syndrome presenting with episodic ataxia","volume":"50","author":"Ohshiro-Sasaki","year":"2014","journal-title":"Pediatr Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1055\/s-0039-1688410","article-title":"Infantile-onset paroxysmal movement disorder and episodic ataxia associated with a TBC1D24 mutation","volume":"50","author":"Zimmern","year":"2019","journal-title":"Neuropediatrics."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1212\/WNL.0000000000003309","article-title":"Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy","volume":"87","author":"Corbett","year":"2016","journal-title":"Neurology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/mdc3.12872","article-title":"Episodic ataxia secondary to CEP290 compound heterozygous mutations: a case report","volume":"7","author":"Hamed","year":"2019","journal-title":"Mov Disord Clin Pract."},{"key":"B61","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/acn3.51005","article-title":"FGF14-related episodic ataxia: delineating the phenotype of Episodic Ataxia type 9","volume":"7","author":"Piarroux","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/humu.22797","article-title":"A gain-of-function mutation in NALCN in a child with intellectual disability, ataxia, and arthrogryposis","volume":"36","author":"Aoyagi","year":"2015","journal-title":"Hum Mutat."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.57.8.1499","article-title":"An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus","volume":"57","author":"Steckley","year":"2001","journal-title":"Neurology."},{"key":"B64","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1212\/01.wnl.0000167186.05465.7c","article-title":"A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia","volume":"65","author":"Cader","year":"2005","journal-title":"Neurology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archneur.1963.00460050021002","article-title":"Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations","volume":"8","author":"Farmer","year":"1963","journal-title":"Arch Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/archneur.1996.00550040074016","article-title":"Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias","volume":"53","author":"Damji","year":"1996","journal-title":"Arch Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/archneur.64.5.749","article-title":"A new episodic ataxia syndrome with linkage to chromosome 19q13","volume":"64","author":"Kerber","year":"2007","journal-title":"Arch Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00415-010-5534-3","article-title":"Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases","volume":"257","author":"Marcel","year":"2010","journal-title":"J Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00415-010-5748-4","article-title":"Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings","volume":"258","author":"Li","year":"2011","journal-title":"J Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jns.2014.04.008","article-title":"Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis","volume":"341","author":"Piffer","year":"2014","journal-title":"J Neurol Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1212\/01.WNL.0000130252.69304.D2","article-title":"Paroxysmal dysarthria and ataxia after midbrain infarction","volume":"63","author":"Matsui","year":"2004","journal-title":"Neurology."},{"key":"B72","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/BF00878879","article-title":"Paroxysmal dysarthria and ataxia in a patient with Beh\u00e7et's disease","volume":"242","author":"Akman-Demir","year":"1995","journal-title":"J Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1212\/NXI.0000000000000536","article-title":"Episodic ataxia in CASPR2 autoimmunity","volume":"6","author":"L\u00f3pez Chiriboga","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflam."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1212\/NXI.0000000000000371","article-title":"Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis","volume":"4","author":"Joubert","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflam."},{"key":"B75","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1469-8749.2012.04221.x","article-title":"An unusual presentation of anti-Hu-associated paraneoplastic limbic encephalitis","volume":"54","author":"Langer","year":"2012","journal-title":"Dev Med Child Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1212\/WNL.0b013e3181ea9ee3","article-title":"Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins","volume":"75","author":"Graves","year":"2010","journal-title":"Neurology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.3390\/ijms21207602","article-title":"A common kinetic property of mutations linked to episodic ataxia type 1 studied in the shaker Kv channel","volume":"21","author":"Zhao","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1152\/jn.00437.2007","article-title":"Manipulation of the potassium channel KV1. 1 and its effect on neuronal excitability in rat sensory neurons","volume":"98","author":"Chi","year":"2007","journal-title":"J Neurophysiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neulet.2015.02.039","article-title":"Contribution of persistent sodium currents to the excitability of tonic firing substantia gelatinosa neurons of the rat","volume":"591","author":"Cho","year":"2015","journal-title":"Neurosci Lett."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1111\/j.1460-9568.2008.06211.x","article-title":"Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro","volume":"27","author":"Lamanauskas","year":"2008","journal-title":"Eur J Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/00000542-199609000-00023","article-title":"Riluzole anesthesia: use-dependent block of presynaptic glutamate fibers","volume":"85","author":"MacIver","year":"1996","journal-title":"Anesthesiology."},{"key":"B82","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1152\/jn.00714.2011","article-title":"Effect of prolonged riluzole exposure on cultured motoneurons in a mouse model of ALS","volume":"107","author":"Schuster","year":"2012","journal-title":"J Neurophysiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.bjp.0700905","article-title":"Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study","volume":"120","author":"Siniscalchi","year":"1997","journal-title":"Br J Pharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0014-2999(91)90040-W","article-title":"Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat","volume":"193","author":"Stutzmann","year":"1991","journal-title":"Eur J Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e18681","DOI":"10.1371\/journal.pone.0018681","article-title":"Blockade of persistent sodium currents contributes to the riluzole-induced inhibition of spontaneous activity and oscillations in injured DRG neurons","volume":"6","author":"Xie","year":"2011","journal-title":"PLoS ONE."},{"key":"B86","first-page":"98","article-title":"Computational insights into the neuroprotective action of riluzole on 3-acetylpyridine-induced ataxia in rats","volume":"15","author":"Abbasi","year":"2013","journal-title":"Cell J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0304-3940(00)00780-1","article-title":"Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey","volume":"281","author":"Boraud","year":"2000","journal-title":"Neurosci Lett."},{"key":"B88","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/cns.12355","article-title":"Riluzole is a promising pharmacological inhibitor of bilirubin-induced excitotoxicity in the ventral cochlear nucleus","volume":"21","author":"Han","year":"2015","journal-title":"CNS Neurosci Therap."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/mds.1219","article-title":"Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain","volume":"16","author":"Hassani","year":"2001","journal-title":"Mov Disord."},{"key":"B90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.lfs.2007.10.015","article-title":"Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells","volume":"82","author":"Wang","year":"2008","journal-title":"Life Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/exnr.1997.6554","article-title":"Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies","volume":"147","author":"Stefani","year":"1997","journal-title":"Exp Neurol."},{"key":"B92","first-page":"1280","article-title":"Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons","volume":"282","author":"Huang","year":"1997","journal-title":"J Pharmacol Exp Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1212\/WNL.0b013e3181d31e23","article-title":"Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial","volume":"74","author":"Ristori","year":"2010","journal-title":"Neurology."},{"key":"B94","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","article-title":"Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Romano","year":"2015","journal-title":"Lancet Neurol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1474-4422(16)00117-4","article-title":"Riluzole in patients with hereditary cerebellar ataxia - authors' reply","volume":"15","author":"Romano","year":"2016","journal-title":"Lancet Neurol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S1474-4422(15)00217-3","article-title":"Rare inherited diseases merit disease-specific trials","volume":"14","author":"Durr","year":"2015","journal-title":"Lancet Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.703970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T11:49:16Z","timestamp":1631188156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.703970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":96,"alternative-id":["10.3389\/fneur.2021.703970"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.703970","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"article-number":"703970"}}